Clinical Trials for 131-MIBG

1 Open Trial

Trial TypeProtocol No. &
Open Date
Summary
TreatmentVICCPED1249
08/06/2012
An Open Label, Expanded Access Protocol using 131I-Metaiodobenzylguanidine (131I-MIBG) Therapy in Patients with Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.